Immunofluorescent antibody test for diagnosis of gonorrhoea.
An indirect fluorescent antibody test was evaluated in 198 cases of a high-risk group with a culture prevalence of 37.3% and in 426 cases of a low-risk group with a culture prevalence of 1.16%. A sensitivity of 77.1% in the culture-positive patients with uncomplicated gonorrhoea, and a specificity of 88.7% in the culture- and history-negative cases, was obtained in the high-risk group. In this group, the sera from 88.8% of the patients with culture-proven gonorrhoea became positive in an indirect fluorescent antibody test within 3 weeks of last sexual contact. In the low-risk group, for which the sensitivity could not be determined due to various reasons, a specificity of 95.8% was obtained. Complement fixation test was positive in sera of only 17.6% of the culture-positive cases of the high-risk group.
D000293:Adolescent; D000328:Adult; D000942:Antigens, Bacterial; D002584:Cervix Uteri / Q000382:microbiology; D003937:Diagnosis, Differential; D005069:Evaluation Studies as Topic; D005260:Female; D005455:Fluorescent Antibody Technique; D006069:Gonorrhea / Q000175:diagnosis*; D006801:Humans; D008297:Male; D009344:Neisseria gonorrhoeae / Q000276:immunology* / Q000302:isolation & purification; D010614:Pharynx / Q000382:microbiology; D012007:Rectum / Q000382:microbiology; D012698:Serologic Tests / Q000379:methods*; D014521:Urethra / Q000382:microbiology
D000942:Antigens, Bacterial